Can the FDA pursue more aggressive food regulations under a deregulatory administration?
In this call recap, CFRA’s Washington Analysis team breaks down what’s really happening behind the scenes as the Trump administration pushes forward with its “Make America Healthy Again” (MAHA) food policy agenda. A featured regulatory attorney with deep FDA experience outlines what investors and industry watchers need to know, from proposed front-of-package labeling to the FDA’s early-stage efforts at post-market ingredient reviews.
However, implementing this vision comes with serious challenges—like internal staffing cuts, budget constraints, and unclear science. These roadblocks could delay or derail key food policy initiatives unless the administration reallocates funding or changes course.
With potential implications for consumer brands like Conagra, PepsiCo, and General Mills, as well as fast-food giants like McDonald’s and Yum! Brands, this analysis offers critical insights at a time of regulatory uncertainty.
